Project Grant R00AG081552
Award Date
8/15/24
Completion Date
7/31/27
Dollars Obligated
$523K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
The National Institute on Aging (NIA) awarded a $2,330,235 Project Grant under the Aging Research program (CFDA 93.866) to Rush University Medical Center in Chicago, Illinois. The grant, which runs from September 15, 2024 to June 30, 2029, will support research examining the relationship between diet, neuroinflammation, brain oxidative stress, and plasma neurodegenerative biomarkers in a diverse population to elucidate the link between diet and Alzheimer's disease/age-related dementias...
The National Institute on Aging (NIA) awarded a $656,000 Project Grant (CFDA 93.866 - Aging Research) to The Regents of the University of California, San Francisco (UCSF) to investigate the role of hyperalgesic priming in chronic pain experienced by the elderly. The research aims to: 1) establish that aged rats exhibit nociceptor plasticity (priming) and determine if it is associated with systemic inflammation, and 2) identify the mechanisms underlying priming in the elderly, including the...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), provides $507,371 to the University of Florida to study the role of CASP8 microsatellite repeat expansions in Alzheimer's disease (AD). The project aims to: 1) Investigate the accumulation of CASP8 repeat expansion RNA and proteins in AD patient brains, 2) Examine the association between CASP8 repeat expansions and AD pathological hallmarks in patient-derived...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support Emory University's research into the genetic regulation of brain transcriptomics and proteomics associated with Alzheimer's disease and related dementias. The $528,876 award, effective June 1, 2025, will fund the development of new analytic tools to integrate genomic data across multiple tissues and improve the identification of genetic risk factors and underlying molecular mechanisms for...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to evaluate the effects of poverty alleviation policies on the risk and disparities of Alzheimer's disease and related dementias (AD/ADRD). The $131,813 award to Trustees of Boston University, awarded on May 1, 2025, will support a research program with two key objectives: In the K99 phase, the researcher will integrate Health and Retirement Study (HRS) and Medicare data to quantify state-level...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $479,375 to Florida International University to conduct research on the effect of a small molecule activator of autophagy, TPI-132, on insulin signaling, senescence, and neuropathology in mouse models of Alzheimer's disease. The goal is to optimize TPI-132 to increase its potency, brain penetration, and reduce toxicity, and then evaluate its impacts on neuronal senescence, synapses, protein...
This $338,527 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports research to understand the role of inhibitory interneurons in the pathophysiology of Alzheimer's disease (AD) and related dementias (ADRD). The key objectives are to: 1) Identify disrupted interneuron gene expression in post-mortem AD brain tissue, 2) Characterize inhibitory dysfunction in AD-derived induced interneurons in vitro, and 3) Assess the impact of transplanting healthy...
The National Institute on Aging (NIA) awarded a 2-year, $405,401 Project Grant under the Aging Research program (CFDA 93.866) to the University of Florida to conduct a multi-level analysis of factors influencing the response to medical marijuana treatment for chronic musculoskeletal pain in older adults. The key objectives are to: 1) Identify gene expression modules associated with changes in chronic pain severity following medical marijuana use, 2) Detect associations between changes in chronic...
This $2,356,117 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support research to improve the perioperative management of patients with Alzheimer's disease and related dementias. The primary objectives are to: (1) identify the extent to which surgical patients with these conditions are at increased risk for adverse postoperative outcomes, and (2) estimate the association between various perioperative interventions and the incidence...
This Project Grant from the National Institutes of Health's National Institute on Aging, under the Aging Research program (CFDA 93.866), provides $4,041,438 to develop new computational tools and biomarkers for Alzheimer's disease. The University of Miami will aggregate and analyze DNA methylation datasets to identify age-associated epigenetic changes related to aging and Alzheimer's progression. Researchers will create a searchable web interface to disseminate findings on the role of DNA...